Role: Innovation Chair
Affiliation: UCL Translational Research Office (TRO)
David joined UCL’s Translational Research Office in 2022, as Senior Business & Innovation Manager for the Faculty of Population Health Sciences. He brings a wealth of expertise in biomedical research, business theory, academic:industry partnerships, and key account management. Before joining UCL, David completed a PhD in Ca2+ overload during acute pancreatitis, split between University of Liverpool and RIKEN Tokyo. After a short post-doc at King’s College London, he moved to Queen Mary University of London (QMUL) as coordinator of a large observational trial of genetic risk factors for pituitary adenoma. He transitioned into QMUL BD (Health) team, where he was instrumental in developing the Knowledge Transfer Partnership portfolio, and in securing large grants through NIHR, NHSX and Innovate UK. He is currently completing a Global MBA at Bayes Business School, majoring in University:Company Innovation Ecosystems.
David holds a BSc in Biochemistry (Uni of Nottingham), a PhD in Cell & Molecular Physiology (Uni of Liverpool & RIKEN Japan), and an MBA (Bayes Business School).